Mechanical circulatory support in children: bridge to transplant versus recovery

John L Jefferies1, David L Morales

  • 1The Heart Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 2003, Cincinnati, OH 45229, USA. john.jefferies@cchmc.org

Insights

Pediatric heart failure is rising, necessitating advanced therapies like mechanical circulatory support (MCS). New pediatric ventricular assist devices (VADs) offer promising options beyond traditional bridge-to-transplant strategies.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Biomedical Engineering

Background:

  • Increasing incidence of heart failure in children and adolescents.
  • Mechanical circulatory support (MCS) as a critical advanced therapy.
  • Growing need for pediatric-specific ventricular assist devices (VADs).

Purpose of the Study:

  • Review current mechanical circulatory support (MCS) approaches in pediatric heart failure.
  • Discuss the development and clinical use of pediatric ventricular assist devices (VADs).
  • Explore emerging and future MCS options for pediatric patients.

Main Methods:

  • Literature review of existing clinical data on pediatric MCS.
  • Analysis of current trends in VAD development for children.
  • Discussion of potential future MCS technologies and strategies.

Main Results:

  • Mechanical circulatory support (MCS) is increasingly utilized in pediatric heart failure.
  • Existing adult devices are adapted, and pediatric-specific VADs are under development.
  • Bridge-to-transplant, bridge-to-recovery, and bridge-to-destination are viable MCS strategies in select pediatric cases.

Conclusions:

  • Mechanical circulatory support (MCS) plays a vital role in managing pediatric heart failure.
  • Pediatric-specific VADs are crucial for optimizing outcomes.
  • Future MCS innovations hold promise for improving care for children with advanced heart disease.